Description
| Product Name | Details | CAT.No | Size |
| ASO | Suitable for Hitachi 917 | HIT0501D | R1: 2 x 20ml R2: 1 x 10ml R4: 1 x 1ml |
| ASO Immunoturbidmetry | Suitable for use on Olympus System AU600, AU400, AU640, AU2700 | OLY0501E | R1: 2 x 20ml R2: 1 x 10ml |
| ASO | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF501A | R1: 2 x 9ml R2: 2 x 14ml |
| ASO | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF501B | R1: 6 x 17.2ml R2: 6 x 28.4ml |
Product Description
The Biorex Diagnostics ASO Assay is an in vitro diagnostic test for the quantitative determination of antistreptolysin O antibodies in human serum. These antibodies are produced by the immune system in response to streptolysin O, a toxin released by Streptococcus pyogenes (Group A streptococcus). Measuring antibody levels provides critical clinical information for diagnosing recent or past streptococcal infections and assessing post-infection complications.
Accurate antibody measurement is particularly important for identifying immune-mediated conditions such as rheumatic fever and post-streptococcal glomerulonephritis (PSGN). Elevated titres indicate a recent infection, even when initial symptoms are no longer present, making this assay an essential tool for clinicians in confirming suspected diagnoses, monitoring progression, and guiding patient care.
Key Features
- Quantitative determination of antistreptolysin O antibodies in serum
- Supports diagnosis of rheumatic fever, PSGN, and other post-streptococcal complications
- Compatible with latex agglutination or haemolysis inhibition methods
- Suitable for automated analysers including Hitachi, Olympus, and Furuno/Daytona systems
- Reliable and reproducible across multiple laboratory environments
Benefits
This assay provides precise and clinically meaningful results, enabling laboratories to detect and monitor post-streptococcal illnesses accurately. Its reproducibility ensures consistent performance across diverse laboratory platforms, while automated system compatibility streamlines workflow and increases efficiency.
Routine use allows early diagnosis and ongoing monitoring of immune-mediated complications, supporting better patient management. The assay is also valuable in epidemiological studies and research into streptococcal infections, helping to evaluate population-level immune responses and exposure trends.
By integrating this assay into routine laboratory practice, healthcare professionals gain reliable data for informed decision-making, improving patient outcomes and supporting evidence-based treatment strategies. Its precision, versatility, and ease of use make it an indispensable tool for modern clinical laboratories and infectious disease diagnostics.
Contact Us for more information.